% | $
Quotes you view appear here for quick access.

Vical Incorporated Message Board

  • gofordna gofordna Feb 1, 2013 5:19 PM Flag

    Imagination & Naked DNA franchise

    Imagine how bullish Vical stock would be when either of its strategic platforms -- cancer or CMV -- draw big $$ from another big pharma. I say another big pharma since the Astellas deal brought tens of millions in cash without much more than a market burp. TransVax attracted Astellas.... a top 10 global pharma company, and then Astellas took on further development of the drug with Vical leading in trial design and launch prep, since Vical's next big milestone payment will be triggered when the TransVax trials begin.
    Now imagine a quantum benefit for dying melanoma patients -- tolerable out patient injections + good durable response chances for chemo naive patients + promising & superior survival benefit for responders who get several treatment cycles of Allovectin. Imagine "free" news coverage on networks and business cable reporting the Phase 3 results, ease of manufacturing and drug delivery AND the rising value of Vical as a probable takeover target.
    Now imagine a possible "two-fer." With progress and share price boosts from both the CMV and cancer franchises THIS YEAR.
    In March 2009 -- less than 4 years ago -- who thought the Dow and S&P would more than double by now? I did. And I moved back long on equities. Time will tell when Vical doubles to move back above $7.00.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.3048-0.0150(-4.69%)Feb 12 3:59 PMEST